Monika Fritzer-Szekeres

Monika Fritzer-Szekeres

UNVERIFIED PROFILE

Are you Monika Fritzer-Szekeres?   Register this Author

Register author
Monika Fritzer-Szekeres

Monika Fritzer-Szekeres

Publications by authors named "Monika Fritzer-Szekeres"

Are you Monika Fritzer-Szekeres?   Register this Author

58Publications

967Reads

15Profile Views

Paper-based training diaries for monitoring of performance progress due to long-term physical activity.

Pol Arch Intern Med 2019 10 17;129(10):679-685. Epub 2019 Sep 17.

Department of Cardiology, Medical University of Vienna, Vienna, Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.20452/pamw.14975DOI Listing
October 2019

Sports and HDL-Quality Reflected By Serum Amyloid A and Surfactant Protein B.

Int J Med Sci 2017 3;14(11):1040-1048. Epub 2017 Sep 3.

Medical University of Vienna, Department of Cardiology, Währinger Gürtel 18-20, 1090 Vienna, Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.7150/ijms.20388DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5666533PMC
June 2018

Long-term endurance training increases serum cathepsin S and decreases IL-6 and hsCRP levels.

J Sports Sci 2017 Nov 18;35(21):2129-2134. Epub 2016 Nov 18.

a Department of Cardiology , Medical University of Vienna , Vienna , Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/02640414.2016.1258482DOI Listing
November 2017

Thiosemicarbazone derivatives, thiazolyl hydrazones, effectively inhibit leukemic tumor cell growth: Down-regulation of ribonucleotide reductase activity and synergism with arabinofuranosylcytosine.

Food Chem Toxicol 2017 Oct 14;108(Pt A):53-62. Epub 2017 Jul 14.

Department of Medical and Chemical Laboratory Diagnostics, Medical University of Vienna, Waehringer Guertel 18-20, A-1090 Vienna, Austria; Department of Pathology, Medical University of Vienna, Waehringer Guertel 18-20, A-1090 Vienna, Austria. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.fct.2017.07.029DOI Listing
October 2017

Physical inactivity increases endostatin and osteopontin in patients with coronary artery disease.

Heart Vessels 2016 Oct 11;31(10):1603-8. Epub 2015 Dec 11.

Department of Cardiology, Medical University of Vienna, Währinger Gürtel 18-20, 1090, Vienna, Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00380-015-0778-6DOI Listing
October 2016

Circulating betatrophin correlates with atherogenic lipid profiles but not with glucose and insulin levels in insulin-resistant individuals.

Diabetologia 2014 Jun 13;57(6):1204-8. Epub 2014 Mar 13.

Clinical Division of Endocrinology and Metabolism, Department of Medicine III, Medical University of Vienna, Waehringer Guertel 18-20, 1090, Vienna, Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00125-014-3208-xDOI Listing
June 2014

Association of endostatin with mortality in patients with chronic heart failure.

Eur J Clin Invest 2014 Feb 28;44(2):125-35. Epub 2013 Nov 28.

Department of Clinical Pharmacology, Medical University Vienna, Vienna, Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/eci.12197DOI Listing
February 2014

Exercise increases serum endostatin levels in female and male patients with diabetes and controls.

Cardiovasc Diabetol 2014 Jan 6;13. Epub 2014 Jan 6.

Department of Cardiology, Institute of Internal Medicine II, Medical University of Vienna, Währinger Gürtel 18-20, Vienna 1090, Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/1475-2840-13-6DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3913788PMC
January 2014

Combination effects of digalloylresveratrol with arabinofuranosylcytosine and difluorodeoxycytidine in human leukemia and pancreatic cancer cells.

Nucleosides Nucleotides Nucleic Acids 2011 Dec;30(12):1190-6

Department of Medical and Chemical Laboratory Diagnostics, Medical University of Vienna, General Hospital of Vienna, Vienna, Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/15257770.2011.596497DOI Listing
December 2011

A novel N-hydroxy-N'-aminoguanidine derivative inhibits ribonucleotide reductase activity: Effects in human HL-60 promyelocytic leukemia cells and synergism with arabinofuranosylcytosine (Ara-C).

Biochem Pharmacol 2011 Jan 16;81(1):50-9. Epub 2010 Sep 16.

Department of Medical and Chemical Laboratory Diagnostics, Medical University of Vienna, General Hospital of Vienna, Waehringer Guertel 18-20, A-1090 Vienna, Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bcp.2010.09.006DOI Listing
January 2011

Chemopreventive effects of resveratrol and resveratrol derivatives.

Ann N Y Acad Sci 2011 Jan;1215:89-95

Institute for Laboratory Medicine, Department for Medical, Medical University of Vienna, General Hospital of Vienna, Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/j.1749-6632.2010.05864.xDOI Listing
January 2011

Resveratrol and resveratrol analogues--structure-activity relationship.

Pharm Res 2010 Jun 16;27(6):1042-8. Epub 2010 Mar 16.

Department of Medical and Chemical Laboratory Diagnostics, General Hospital of Vienna, Medical University of Vienna, Waehringer Guertel 18-20, 1090 Vienna, Austria.

View Article

Download full-text PDF

Source
http://link.springer.com/content/pdf/10.1007/s11095-010-0090
Web Search
http://link.springer.com/10.1007/s11095-010-0090-1
Publisher Site
http://dx.doi.org/10.1007/s11095-010-0090-1DOI Listing
June 2010

Antitumor effects of KITC, a new resveratrol derivative, in AsPC-1 and BxPC-3 human pancreatic carcinoma cells.

Invest New Drugs 2009 Oct 8;27(5):393-401. Epub 2008 Oct 8.

Clinical Institute of Medical and Chemical Laboratory Diagnostics, General Hospital of Vienna, Medical University of Vienna, Waehringer Guertel 18-20, A-1090, Vienna, Austria.

View Article

Download full-text PDF

Source
http://link.springer.com/10.1007/s10637-008-9183-7
Publisher Site
http://dx.doi.org/10.1007/s10637-008-9183-7DOI Listing
October 2009

Digalloylresveratrol, a new phenolic acid derivative induces apoptosis and cell cycle arrest in human HT-29 colon cancer cells.

Cancer Lett 2009 Feb 25;274(2):299-304. Epub 2008 Oct 25.

Clinical Institute of Medical and Chemical Laboratory Diagnostics, Medical University of Vienna, General Hospital of Vienna, Waehringer Guertel 18-20, A-1090 Vienna, Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.canlet.2008.09.020DOI Listing
February 2009

Biochemical effects of piceatannol in human HL-60 promyelocytic leukemia cells--synergism with Ara-C.

Int J Oncol 2008 Oct;33(4):887-92

Clinical Institute of Medical and Chemical Laboratory Diagnostics, Medical University of Vienna, General Hospital of Vienna, A-1090 Vienna, Austria.

View Article

Download full-text PDF

Source
October 2008

Synergistic effects of deuterium oxide and gemcitabine in human pancreatic cancer cell lines.

Cancer Lett 2008 Feb 26;259(2):231-9. Epub 2007 Nov 26.

Clinical Institute of Medical and Chemical Laboratory Diagnostics, Medical University of Vienna, General Hospital of Vienna, Waehringer Guertel 18-20, A-1090 Vienna, Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.canlet.2007.10.010DOI Listing
February 2008

Novel resveratrol derivatives induce apoptosis and cause cell cycle arrest in prostate cancer cell lines.

Anticancer Res 2007 Sep-Oct;27(5A):3459-64

Clinical Institute of Medical and Chemical Laboratory Diagnostics, Waehringer Guertel 18-20, A-1090, Vienna, Austria.

View Article

Download full-text PDF

Source
November 2007

Avemar, a nontoxic fermented wheat germ extract, induces apoptosis and inhibits ribonucleotide reductase in human HL-60 promyelocytic leukemia cells.

Cancer Lett 2007 Jun 29;250(2):323-8. Epub 2006 Nov 29.

Clinical Institute of Medical and Chemical Laboratory Diagnostics, Medical University of Vienna, General Hospital of Vienna, Waehringer Guertel 18-20, A-1090 Vienna, Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.canlet.2006.10.018DOI Listing
June 2007

Gallic acid inhibits ribonucleotide reductase and cyclooxygenases in human HL-60 promyelocytic leukemia cells.

Cancer Lett 2007 Jan 20;245(1-2):156-62. Epub 2006 Feb 20.

Clinical Institute of Medical and Chemical Laboratory Diagnostics, Medical University of Vienna, General Hospital of Vienna, Waehringer Guertel 18-20, A-1090 Vienna, Austria.

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S03043835060002
Publisher Site
http://dx.doi.org/10.1016/j.canlet.2006.01.001DOI Listing
January 2007

Cytotoxic and biochemical effects of 3,3',4,4',5,5'-hexahydroxystilbene, a novel resveratrol analog in HL-60 human promyelocytic leukemia cells.

Exp Hematol 2006 Oct;34(10):1377-84

Clinical Institute of Medical and Chemical Laboratory Diagnostics, General Hospital of Vienna, Medical University of Vienna, Vienna, Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.exphem.2006.05.018DOI Listing
October 2006

Effects of heavy water (D2O) on human pancreatic tumor cells.

Anticancer Res 2005 Sep-Oct;25(5):3407-11

Clinical Institute of Medical and Chemical Laboratory Diagnostics, Medical University of Vienna, General Hospital of Vienna, Waehringer Guertel 18-20, A-1090 Vienna, Austria.

View Article

Download full-text PDF

Source
October 2005

Heterodinucleoside phosphates of 5-fluorodeoxyuridine and arabinofuranosylcytosine--new drugs in cancer chemotherapy?

In Vivo 2005 Jan-Feb;19(1):205-14

Clinical Institute of Medical and Chemical Laboratory Diagnostics, Medical University of Vienna, A-1090 Vienna, Austria.

View Article

Download full-text PDF

Source
August 2005

Synergistic action of resveratrol, an ingredient of wine, with Ara-C and tiazofurin in HL-60 human promyelocytic leukemia cells.

Exp Hematol 2005 Mar;33(3):329-35

Clinical Institute of Medical and Chemical Laboratory Diagnostics, General Hospital of Vienna, Medical University of Vienna, Vienna, Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.exphem.2004.11.009DOI Listing
March 2005

Immunologic and biochemical effects of the fermented wheat germ extract Avemar.

Exp Biol Med (Maywood) 2005 Feb;230(2):144-9

Clinical Institute of Medical and Chemical Laboratory Diagnostics, Medical University of Vienna, General Hospital of Vienna, Waehringer Guertel 18-20, A-1090 Vienna, Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/153537020523000209DOI Listing
February 2005

Combination chemotherapy of BCNU and Didox acts synergystically in 9L glioma cells.

Nucleosides Nucleotides Nucleic Acids 2004 Oct;23(8-9):1531-5

Clinical Institute of Medical and Chemical Laboratory Diagnostics, University of Vienna, Vienna, Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1081/NCN-200027746DOI Listing
October 2004

Synergistic cytotoxicity of the ribonucleotide reductase inhibitor didox (3,4-dihydroxy-benzohydroxamic acid) and the alkylating agent carmustine (BCNU) in 9L rat gliosarcoma cells and DAOY human medulloblastoma cells.

Cancer Chemother Pharmacol 2004 Aug 4;54(2):139-45. Epub 2004 May 4.

General Hospital of Vienna, Clinical Institute of Medical and Chemical Laboratory Diagnostics, Medical University of Vienna, 5H Waehringer Guertel 18-20, 1090, Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00280-004-0795-0DOI Listing
August 2004

Combination effects of Ara-C and 5-fluorodeoxyuridine against leukemia cells in vitro and in mice.

Anticancer Res 2003 Sep-Oct;23(5A):3841-6

Cancer Research Institute, Slovak Academy of Sciences, Bratislava, Slovakia.

View Article

Download full-text PDF

Source
February 2004

Biochemical modulation of Ara-C effects by amidox, an inhibitor of ribonucleotide reductase in HL-60 promyelocytic human leukemia cells.

Life Sci 2004 Jan;74(9):1071-80

Clinical Institute for Medical and Chemical Laboratory Diagnostics, School of Medicine, University of Vienna, General Hospital of Vienna, Waehringer Guertel 18-20, 1090 Vienna, Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.lfs.2003.06.043DOI Listing
January 2004

Trimidox, an inhibitor of ribonucleotide reductase, synergistically enhances the inhibition of colony formation by Ara-C in HL-60 human promyelocytic leukemia cells.

Biochem Pharmacol 2002 Aug;64(3):481-5

Clinical Institute for Medical and Chemical Laboratory Diagnostics, General Hospital of Vienna, Medical School, University of Vienna, Waehringer Guertel 18-20, A-1090, Vienna, Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/s0006-2952(02)01186-3DOI Listing
August 2002